Category: IBS News

Valeant to Acquire Specialty Salix Pharma

Valeant Pharmaceuticals has reached an agreement to acquire Salix Pharma in a cash deal that values the gastrointestinal drug company at $14.5 billion, the companies said Sunday. Under the definitive agreement, Valeant (NYSE:VRX) based near Montreal, Canada, will acquire Raleigh, NC-based Salix (NASDAQ: SLXP) for $158 per share, a …

Food Components and Irritable Bowel Syndrome

Click Here To Read The Full Text Ingestion of food has long been linked with gut symptoms, and there is increasing interest in using diet in the management of patients with irritable bowel syndrome (IBS). The West has developed an intense interest in specialized, restrictive diets, such as …

IBD patients are misdiagnosed with irritable bowel syndrome IBS

A new study, published in the latest issue of the UEG Journal reveals that 10 percent of inflammatory bowel disease (IBD) patients are misdiagnosed with irritable bowel syndrome (IBS), and in 3 percent of cases the misdiagnosis can persist for five or more years. The case-controlled study, conducted …

New Guidelines Address Irritable Bowel Syndrome Drugs

Up to 15 percent of the general adult population is affected by irritable bowel syndrome (IBS), and most patients struggle to find effective drug therapy. A new guideline from the American Gastroenterological Association (AGA) provides these patients and their physician’s guidance. The new guideline and accompanying technical review …